Statistics

Total Visits

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)66

Select a period of time:

Number of views in the range

Views
Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)4

Views

Views
November 20251
December 20250
January 20260
February 20260
March 20262
April 20261
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Bolivia1
United Kingdom1
Turkey1
United States1
 

Top cities views

Views
Ankara1
La Paz1
Long Beach1